From Chemical to Drug: The Path to a Small Molecule IND

Please join the JPOD @ Philadelphia's panel of experts to learn best practices when filing small molecule Investigational New Drug (IND) applications!

Do you have a solid plan to achieve IND acceptance? Filing an Investigational New Drug (IND) application might be the next step in advancing your company's early-stage drug development program. Johnson & Johnson Innovation, JLABS and Janssen R&D invite you to an in-depth look into the process of filing an IND. Whether your goal is to develop a pipeline through commercial launch or partner as early as possible, submitting an IND is a critical early milestone for every biotech company. With big Pharma and VC firms competing for the most promising compounds, startups are expected to demonstrate a clear blueprint for IND approval, and we want you to be ready.

Learn more about the panelists and register here!

#JLABS #JPODPhilly